Market revenue in 2023 | USD 64.6 million |
Market revenue in 2030 | USD 108.0 million |
Growth rate | 7.6% (CAGR from 2023 to 2030) |
Largest segment | Outpatient facilities |
Fastest growing segment | Home Care |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hospitals, Outpatient Facilities, Home Care, Research & Manufacturing |
Key market players worldwide | BD, Danaher Corp, Koninklijke Philips NV, Qiagen NV, Thermo Fisher Scientific Inc, Myriad Genetics Inc, Argon Medical Devices, Roche Holding AG ADR, Hologic Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to breast cancer diagnostics market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 63.78% in 2023. Horizon Databook has segmented the Saudi Arabia breast cancer diagnostics market based on hospitals, outpatient facilities, home care, research & manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
Saudi Arabia breast cancer drugs market is expected to grow at a steady rate. Increasing incidence of cancer in Saudi Arabia is expected to drive the overall market. According to statistics published by WHO, in 2018, 24,485 new cancer cases were identified. In addition, 10,518 people died in 2018 due to cancer. Breast cancer is a common malignancy among women in the country.
According to data published in PLOS, the prevalence of breast cancer was 21.8% in 2018. High unmet clinical needs; increased disposable incomes; and collaborations among government, local payers, & international organizations (such as WHO & UN) are expected to provide a wide platform for market growth, attracting the attention of key global players.
The proactive government initiative also provides free breast cancer. However, the issue arises with women in the country that are not willing to undergo screening owing to lack of public awareness. About 92% of women never get a mammography done.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia breast cancer diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia breast cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account